Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
11:03am, Wednesday, Aug 13, 2025
Dogwood Therapeutics, Inc. (NASDAQ: VIRI) - Quick read: What's happening inside
- Status: Pre‑revenue development-stage biopharma. Halneuron® (TTX NaV1.7 program) is lead asset; Phase 2b HALT‑CINP‑203 dosing commenced in Q1 2025. Interim analysis planned Q4 2025; topline expected H2 2026.
- Rece...
11:02am, Wednesday, Aug 13, 2025
Agape ATP Corporation (NASDAQ: ATPC) - Quick take
What's happening: management completed a large equity raise (46,000,000 shares) and deposited $23,000,000 with a third‑party manager (Bi Cheng) to fund future investments. The company is diversifying from health & wellness into green energy, which...
11:01am, Wednesday, Aug 13, 2025
Wright Investors' Service Holdings, Inc. (PINK: IWSH) - Quick read on what's happening inside the company
Amounts below are presented in thousands (except per-share amounts) as reported in the Form 10‑Q for the quarter ended June 30, 2025.
Key facts & statistics
* Cash and cash equivalents: 394 (...
10:07am, Wednesday, Aug 13, 2025
Loar Holdings Inc. (NYSE: LOAR)
Here's what's happening inside the company and what the income statement tells investors - straight, concise and factual.
Key facts & metrics (from Form 10‑Q for quarter ended June 30, 2025):
* Net sales - $123,123 (Q2 2025); $237,782 (six months ended 6/30/25) ...
10:06am, Wednesday, Aug 13, 2025
Tecogen Inc. (NASDAQ: TGEN) - quick read on what's happening inside the company
Bottom line
* The company is scaling product shipments (new chiller deliveries + cogeneration) and saw meaningful revenue growth, but remains unprofitable and burning cash. Management closed a material equity raise af...
10:06am, Wednesday, Aug 13, 2025
Connect Biopharma Holdings Limited (NASDAQ: CNTB) - quick company snapshot and income-statement takeaways.
What's happening inside the company
* Clinical progress: presented supportive clinical and preclinical rademikibart data at major conferences; initiated two Phase 2 acute-exacerbation trials...
10:05am, Wednesday, Aug 13, 2025
Nucor Corporation (NYSE: NUE) - Quick read
Snapshot
- Report: Form 10‑Q for quarter ended July 5, 2025 (unaudited).
- Business: Vertically integrated steel producer (steel mills, steel products, raw materials).
Key facts & statistics (selected, all figures from the 10‑Q)
- Net sales (three months...
10:04am, Wednesday, Aug 13, 2025
BiomX Inc. (NYSE: PHGE) - quick read
What's happening inside:
BiomX is advancing two core clinical programs after its APT acquisition (March 2024): BX004 (CF inhaled phage) has entered a randomized Phase 2b with first patient dosed July 14, 2025; BX211 (DFO) reported positive Phase 2 results in M...
10:02am, Wednesday, Aug 13, 2025
Sanara MedTech Inc. (OTCMKTS: SMTI) - Quick take
What's happening: revenue and gross profit accelerated in H1 2025 while the company invests heavily in its THP value‑based wound‑care buildout and strategic investments; debt and interest costs rose sharply after the CRG term loan and several acqui...
10:01am, Wednesday, Aug 13, 2025
Snapshot - Neonode Inc. (NASDAQ: NEON)
Short take: revenue and license-fee declines drive wider operating losses in Q2 2025 despite very high gross margins and a stable cash runway. Company remains small, concentrated, and loss-making but with liquidity for ~12 months per management.
Key facts & ...
10:00am, Wednesday, Aug 13, 2025
Snapshot - International Isotopes Inc. (OTCMKTS: INIS)
What's happening inside the company
International Isotopes is running its five core segments (Theranostics, Cobalt, Nuclear Medicine Standards, Medical Devices, Fluorine). Management is prioritizing core revenue-producing segments while inves...
09:12am, Wednesday, Aug 13, 2025
Artelo Biosciences, Inc. (NASDAQ: ARTL) - quick read on what's happening inside the company
Short summary: Artelo remains a clinical‑stage biotech advancing lipid‑signaling/cannabinoid programs (ART27.13, ART26.12, ART12.11) while aggressively funding operations through equity, convertible notes ...
09:11am, Wednesday, Aug 13, 2025
Indaptus Therapeutics, Inc. (NASDAQ: INDP) - Quick take
Short summary: the company is a clinical‑stage biotech advancing its lead candidate Decoy20. Financially it's burning cash while raising capital through a SEPA, private placements and convertible notes; management completed a reverse split a...
09:10am, Wednesday, Aug 13, 2025
Snapshot - Worksport Ltd. (WKSP) (PINK: WKSP)
Quick take: The company is scaling U.S. manufacturing, expanding distribution and launching SOLIS & COR products, driving strong top-line growth. Liquidity and recurring losses remain the key risks: cash fell to $1.39M, the accumulated deficit is $72....
09:09am, Wednesday, Aug 13, 2025
Ovid Therapeutics Inc. (NASDAQ: OVID) - Quick internal read
What's happening inside: management is shrinking costs and pausing at least one program while pursuing strategic alternatives to extend runway. A one‑time Marinus payment boosted Q2 revenue; prior period's large "other income" was a one-...
